Anavex Life Sciences Corp (AVXL) — Strategic Asset Allocation Index
Anavex Life Sciences Corp (AVXL) has a Strategic Asset Allocation Index of 0.0% as of September 2018. Strategic assets (PP&E of $0.00 plus long-term investments of $-) total $0.00, measured against net assets of $20.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Anavex Life Sciences Corp's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Anavex Life Sciences Corp Strategic Asset Allocation Index (2014–2018)
This chart shows how Anavex Life Sciences Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2014 to 2018. As of September 2018, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $20.49 Million USD. For live market cap and overall valuation, see Anavex Life Sciences Corp market capitalisation.
Annual Strategic Asset Allocation Index for Anavex Life Sciences Corp (2014–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Anavex Life Sciences Corp from 2014 to 2018, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Anavex Life Sciences Corp book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 0.0% | $0.00 | $0.00 | $- | $20.49 Million | ▲ +0.0 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $24.25 Million | ▲ +0.0 pp |
| 2016 | 0.0% | $0.00 | $0.00 | $- | $6.31 Million | ▼ 0.0 pp |
| 2015 | 0.0% | $1.25K | $1.25K | $- | $12.81 Million | ▼ -1.2 pp |
| 2014 | 1.2% | $2.25K | $2.25K | $- | $192.63K | — |